Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer. [electronic resource]
- International journal of cancer Nov 2015
- 2513-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-0215
10.1002/ijc.29612 doi
Aromatase Inhibitors--therapeutic use Breast Neoplasms--drug therapy DNA, Neoplasm--blood Drug Resistance, Neoplasm Estrogen Receptor alpha--genetics Female Humans Mutation Neoplasm Metastasis Neoplastic Cells, Circulating--pathology Polymerase Chain Reaction--methods Retrospective Studies